000 01631 a2200457 4500
005 20250517074421.0
264 0 _c20161109
008 201611s 0 0 eng d
022 _a1502-7708
024 7 _a10.3109/00365521.2015.1136352
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHoldam, Anne Sofie Krogh
245 0 0 _aBiological therapy increases the health-related quality of life in patients with inflammatory bowel disease in a clinical setting.
_h[electronic resource]
260 _bScandinavian journal of gastroenterology
_c2016
300 _a706-11 p.
_bdigital
500 _aPublication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
650 0 4 _aAdalimumab
_xtherapeutic use
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAnti-Inflammatory Agents
_xtherapeutic use
650 0 4 _aBiological Therapy
650 0 4 _aCase-Control Studies
650 0 4 _aFemale
650 0 4 _aFollow-Up Studies
650 0 4 _aHealth Status Indicators
650 0 4 _aHumans
650 0 4 _aInflammatory Bowel Diseases
_xdrug therapy
650 0 4 _aInfliximab
_xtherapeutic use
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aQuality of Life
650 0 4 _aRetrospective Studies
650 0 4 _aSurveys and Questionnaires
650 0 4 _aTreatment Outcome
650 0 4 _aYoung Adult
700 1 _aBager, Palle
700 1 _aDahlerup, Jens Frederik
773 0 _tScandinavian journal of gastroenterology
_gvol. 51
_gno. 6
_gp. 706-11
856 4 0 _uhttps://doi.org/10.3109/00365521.2015.1136352
_zAvailable from publisher's website
999 _c25654927
_d25654927